Life Healthcare Group Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Life Healthcare Group Holdings wird ein jährliches Gewinn- und Umsatzwachstum von 14.9% bzw. 6.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 14.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 15.5% betragen.

Wichtige Informationen

14.9%

Wachstumsrate der Gewinne

14.8%

EPS-Wachstumsrate

Healthcare Gewinnwachstum28.5%
Wachstumsrate der Einnahmen6.6%
Zukünftige Eigenkapitalrendite15.5%
Analystenabdeckung

Good

Zuletzt aktualisiert29 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Aug 05
Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17

May 30
Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17

Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital

Apr 20
Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital

Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Mar 18
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends

Dec 24
Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends

We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings

Nov 24
We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings

Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25

Nov 23
Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25

An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued

Sep 14
An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued

Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Aug 15
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)

Jul 31
Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)

Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?

May 19
Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?

Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital

Apr 28
Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital

An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued

Feb 08
An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued

There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Jan 25
There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For

Jan 08
With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For

Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?

Nov 28
Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?

Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?

Oct 19
Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?

Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return

Aug 16
Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return

We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt

Jul 20
We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt

Capital Allocation Trends At Life Healthcare Group Holdings (JSE:LHC) Aren't Ideal

May 14
Capital Allocation Trends At Life Healthcare Group Holdings (JSE:LHC) Aren't Ideal

How Many Life Healthcare Group Holdings Limited (JSE:LHC) Shares Did Insiders Buy, In The Last Year?

Mar 21
How Many Life Healthcare Group Holdings Limited (JSE:LHC) Shares Did Insiders Buy, In The Last Year?

Gewinn- und Umsatzwachstumsprognosen

JSE:LHC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (ZAR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
9/30/202627,9692,0271,6784,2077
9/30/202526,2521,7961,4093,8047
9/30/202424,4791,517-203,7686
3/31/202423,7611,4102,9544,556N/A
12/31/202323,3261,3323,0514,613N/A
9/30/202322,8901,2543,1474,670N/A
3/31/202318,0781,2252,5513,494N/A
12/31/202219,4141,2652,6543,839N/A
9/30/202220,7501,3052,7574,184N/A
3/31/202227,6211,5442,2184,615N/A
12/31/202127,3401,6062,7314,879N/A
9/30/202127,0591,6673,2435,142N/A
3/31/202124,5956292,6784,128N/A
12/31/202024,2996682,3784,085N/A
9/30/202024,0037062,0774,041N/A
6/30/202025,0061,860N/AN/AN/A
3/31/202026,0093,0142,2754,555N/A
12/31/201925,9572,7922,4354,605N/A
9/30/201925,9042,5692,5954,655N/A
6/30/201925,3481,8622,3444,518N/A
3/31/201924,7921,1552,0934,380N/A
12/31/201824,2541,3652,1454,410N/A
9/30/201823,7161,5752,1964,440N/A
6/30/201823,1841,5112,3374,427N/A
3/31/201822,6521,4472,4784,413N/A
12/31/201721,8101,131N/A4,069N/A
9/30/201720,967814N/A3,724N/A
6/30/201719,656805N/A3,494N/A
3/31/201718,345795N/A3,263N/A
12/31/201617,4561,206N/A3,159N/A
9/30/201616,5671,616N/A3,055N/A
6/30/201616,0341,808N/A3,076N/A
3/31/201615,5001,999N/A3,096N/A
12/31/201515,1381,933N/A3,024N/A
9/30/201514,7761,866N/A2,951N/A
6/30/201514,3791,830N/A2,809N/A
3/31/201513,9821,793N/A2,667N/A
12/31/201413,5452,284N/A2,602N/A
9/30/201413,1072,774N/A2,536N/A
6/30/201412,7952,772N/A2,642N/A
3/31/201412,4832,770N/A2,748N/A
12/31/201312,1972,241N/A2,683N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: LHCDas prognostizierte Gewinnwachstum (14.9% pro Jahr) liegt über der Sparquote (9.7%).

Ertrag vs. Markt: LHCDie Erträge des Unternehmens (14.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt ZA (20.2% pro Jahr).

Hohe Wachstumserträge: LHCDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: LHCDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt ZA (3.6% pro Jahr).

Hohe Wachstumseinnahmen: LHCDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: LHCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (15.5%).


Wachstumsunternehmen entdecken